Lipocine announced that Jyrki Mattila, MD, PhD, MBA has been named as its executive vice president and chief business officer. Dr. Mattila will oversee the company's business development and commercialisation efforts. Most recently, Dr. Mattila has served as chief business officer at iCeutica Operations as well as president and CEO of LZ Therapeutics.

Previously, Dr. Mattila has worked as executive vice president of Business Development, Product Development and Technical Operations at Auxilium Pharmaceutical as well as president of Orion Pharma.